Identification of Potential Serum Protein Biomarkers in Thymoma with Myasthenia Gravis After Docetaxel Treatment.

Yang, Hongxia; Qi, Guoyan; Dong, Huimin; Liu, Ze; Ma, Mei; Liu, Peng

Yang, Hongxia; Qi, Guoyan; Dong, Huimin; Liu, Ze; Ma, Mei; Liu, Peng.

Afiliación

Yang H; Center of Treatment of Myasthenia Gravis, People's Hospital of Shijiazhuang Affiliated to Hebei Medical University, 365 Jianhua Nan Street, Shijiazhuang, Hebei, China.
Qi G; Hebei Provincial Clinical Research Center for Myasthenia Gravis, Shijiazhuang, China.
Dong H; Center of Treatment of Myasthenia Gravis, People's Hospital of Shijiazhuang Affiliated to Hebei Medical University, 365 Jianhua Nan Street, Shijiazhuang, Hebei, China. qiguoyan@hebmu.edu.cn.
Liu Z; Hebei Provincial Key Laboratory of Myasthenia Gravis, Shijiazhuang, China. qiguoyan@hebmu.edu.cn.
Ma M; Hebei Provincial Clinical Research Center for Myasthenia Gravis, Shijiazhuang, China. qiguoyan@hebmu.edu.cn.
Liu P; Center of Treatment of Myasthenia Gravis, People's Hospital of Shijiazhuang Affiliated to Hebei Medical University, 365 Jianhua Nan Street, Shijiazhuang, Hebei, China.

Neurol Ther ; 12(2): 559-570, 2023 Apr.

Article en En | MEDLINE | ID: mdl-36786935

Palabras clave

Docetaxel; Myasthenia gravis; Thymoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Aspecto: Patient_preference Idioma: En Revista: Neurol Ther Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google